MINI JOMARTIN: Open Payments
NPI 1457720880 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 14 payments from 6 companies in 2025. Trend: 2023 $218 · 2024 $487 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $251 |
| ARGENX US, INC. | 6 | $206 |
| Lundbeck LLC | 2 | $120 |
| ABBVIE INC. | 1 | $115 |
| Abbott Laboratories | 1 | $29 |
| Alexion Pharmaceuticals, Inc. | 1 | $15 |
Products named: WAINUA, VYVGART, VYEPTI, QULIPTA, VYVGART HYTRULO, AMPLATZER, ULTOMIRIS.
Industry payments across NJ — which companies pay providers there.
